SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-15-002593
Filing Date
2015-08-10
Accepted
2015-08-07 21:31:16
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FROM 10-Q mbvx-june302015.htm 10-Q 797848
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13110
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 13083
4 EXHIBIT 32 ex32-1.htm EX-32 11298
  Complete submission text file 0001415889-15-002593.txt   3044902

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mbvx-20150630.xml EX-101.INS 343175
6 XBRL TAXONOMY EXTENSION SCHEMA mbvx-20150630.xsd EX-101.SCH 37034
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbvx-20150630_cal.xml EX-101.CAL 38723
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbvx-20150630_def.xml EX-101.DEF 154527
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbvx-20150630_lab.xml EX-101.LAB 274183
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbvx-20150630_pre.xml EX-101.PRE 217827
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31265 | Film No.: 151039026
SIC: 2834 Pharmaceutical Preparations